Canary Capital launches Injective staking ETF on Nasdaq

Reading Time: < 1 minute

Canary Capital has launched an exchange-traded fund tracking Injective’s native INJ token, giving investors exposure to the asset and potential staking rewards. The Canary Staked INJ ETF trades on Nasdaq under the ticker INJC.

The fund participates in Injective’s proof-of-stake validation process to earn additional INJ tokens. Net staking rewards will be reflected in the ETF’s net asset value.

Canary Capital CEO Steven McClurg said the fund targets investors interested in blockchain networks focused on financial applications. Injective is a Layer 1 blockchain designed for on-chain trading, derivatives and tokenisation. Its native token rose more than 5% on Thursday.